Impaired plasma B-type natriuretic peptide clearance in human septic shock

Critical Care Medicine

Volumn 36, Issue 9, 2008, Pages 2542-2546

  Pirracchio, Romain ^a   Deye, Nicolas ^b   Lukaszewicz, Anne Claire ^a   Mebazaa, Alexandre ^a   Cholley, Bernard ^a   Matéo, Joaquim ^a   Mégarbane, Bruno ^b   Launay, Jean Marie ^b   Peynet, Jacqueline ^b   Baud, Frédéric ^b   Payen, Didier ^a  

^a Lariboisiere Hospital   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

B type natriuretic peptide; Clearance; NEP 24.11; Sepsis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE 1; BRAIN NATRIURETIC PEPTIDE 2; MEMBRANE METALLOENDOPEPTIDASE; NEUTRAL ENDOPEPTIDASE 24.11; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUOROMETRY; HEART STROKE VOLUME; HEART VENTRICLE; HORMONE RELEASE; HUMAN; LIQUID; MALE; OBSERVATIONAL STUDY; PLASMA CLEARANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; BLOOD; DEMOGRAPHY; HEMODYNAMICS; HOSPITALIZATION; METABOLISM; MIDDLE AGED;

BIOLOGICAL MARKERS; DEMOGRAPHY; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

EID: 53049103074     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318183f067     Document Type: Article

References (29)

1. Mukoyama M, Nakao K, Hosoda K, et al: Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-1412
2. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998; 339: 321-328
3. Charles CJ, Espiner EA, Nicholls MG, et al: Clearance receptors and endopeptidase 24.11: Equal role in natriuretic peptide metabolism in conscious sheep. Am J Physiol 1996; 271:R373-R380
4. Erdos EG, Skidgel RA: Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. Faseb J 1989; 3:145-151
5. Hall C: Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004; 6:257-260
6. Potter LR, Abbey-Hosch S, Dickey DM: Na-triuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006; 27: 47-72
7. Charpentier J, Luyt CE, Fulla Y, et al: Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32:660-665
8. Roch A, Allardet-Servent J, Michelet P, et al: NH2 terminal pro-brain natriuretic pep-tide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 2005; 33: 1001-1007
9. Hoffmann U, Brueckmann M, Bertsch T, et al: Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin Lab 2005; 51: 373-379
10. Maeder M, Fehr T, Rickli H, et al: Sepsis-associated myocardial dysfunction: Diagnostic and prognostic impact of cardiac tro-ponins and natriuretic peptides. Chest 2006; 129:1349-1366
11. Bar SL, Swiggum E, Straatman L, et al: Non-heart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis. Can J Cardiol 2006; 22: 263-266
12. Rudiger A, Gasser S, Fischler M, et al: Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 2006; 34:2140-2144
13. Shor R, Rozenman Y, Bolshinsky A, et al: BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 2006; 17:536-540
14. McLean AS, Huang SJ, Hyams S, et al: Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007; 35:1019-1026
15. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101:1481-1483
16. Valtier B, Cholley BP, Belot JP, et al: Nonin-vasive monitoring of cardiac output in critically ill patients using transesophageal Dopp-ler. Am J Respir Crit Care Med 1998; 158: 77-83
17. Michard F, Boussat S, Chemla D, et al: Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 2000; 162: 134-138
18. Nieminen MS, Bohm M, Cowie MR, et al: Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26:384-416
19. Yandle T, Richards M, Smith M, et al: Assay of endopeptidase-24.11 activity in plasma applied to in vivo studies of endopeptidase inhibitors. Clin Chem 1992; 38:1785-1791
20. Brueckmann M, Huhle G, Lang S, et al: Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005; 112:527-534
21. Davis M, Espiner E, Richards G, et al: Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994; 343:440-444
22. Dao Q, Krishnaswamy P, Kazanegra R, et al: Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001; 37:379-385
23. Maisel AS, Krishnaswamy P, Nowak RM, et al: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167
24. Galvani M, Ferrini D, Ottani F: Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Eur J Heart Fail 2004; 6:327-333
25. Remme WJ, Swedberg K: Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-1560
26. Tanaka T, Kanda T, Takahashi T, et al: Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res 2004; 32:57-61
27. Ma KK, Ogawa T, de Bold AJ: Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004; 36: 505-513
28. He Q, LaPointe MC: Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension 1999; 33:283-289
29. Martens A, Eppink GJ, Woittiez AJ, et al: Neutrophil function capacity to express CD10 is decreased in patients with septic shock. Crit Care Med 1999; 27:549-553